Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tiaochang Xiaoyan Pian (TCXYT) is a traditional Chinese medicine (TCM) botanical formulation derived from the classical Xianglian pill, historically used for the treatment of chronic dysentery. It is primarily investigated for its therapeutic effects in ulcerative colitis and chronic colitis. The drug functions by inhibiting the TLR9/MyD88/IRAK signaling pathway, which leads to the activation of macrophage lysosomes and a subsequent reduction in intestinal inflammation. Research and clinical trials for this formulation are largely driven by institutions such as the Second Affiliated Hospital of Guangzhou University of Chinese Medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tiaochang Xiaoyan Pian.